Source comparison
PT-141 Erectile Function Results Timeline Expect: Comparison Across Doses and User Profiles
| Dose | Onset Window | Peak Effect Time | Duration | Nausea Incidence | Ideal Use Case | Professional Assessment ||—|—|—|—|—|—|| 0.5mg | 90–150 min | 3–4 hours | 6–12 hours | 5–10% | First-time users testing sensitivity; minimal side effect risk but often sub
This comparison does not assign a generated winner or score.
- | Dose | Onset Window | Peak Effect Time | Duration | Nausea Incidence | Ideal Use Case | Professional Assessment ||—|—|—|—|—|—|| 0.5mg | 90–150 min | 3–4 hours | 6–12 hours | 5–10% | First-time users testing sensitivity; minimal side effect risk but often subtherapeutic for erectile dysfunction | Useful for baseline assessment but rarely sufficient for consistent erectile enhancement || 0.75mg | 60–120 min | 2–3 hours | 8–16 hours | 10–15% | Standard starting dose for most users; balances efficacy with tolerability | Optimal starting point. Produces measurable response in 60% of users with low discontinuation rate || 1.25mg | 45–90 min | 90 min–2 hours | 12–20 hours | 20–25% | Intermediate dose for users who found 0.75mg insufficient | Sweet spot for many users after initial tolerance established || 1.75mg | 45–75 min | 90 min–2 hours | 12–24 hours | 30–40% | Clinical trial standard dose; maximal efficacy with manageable side effects in most users | Highest evidence-backed dose. JAMA